Impact of Preventive and Therapeutic Zinc Supplementation Programs Among Young Children

NACompletedINTERVENTIONAL
Enrollment

7,680

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Zinc DeficiencyDiarrheaMalaria
Interventions
DIETARY_SUPPLEMENT

Daily preventive Zn; placebo treatment

7 mg zinc / day and placebo supplement during diarrhea episodes

DIETARY_SUPPLEMENT

Therapeutic Zn; daily placebo

20 mg zinc / day for 10 days during diarrhea episodes and daily placebo supplement

DIETARY_SUPPLEMENT

Intermittent Zn; placebo treatment

10 mg zinc for 10 days every 3 months, placebo supplements daily for all other days during 12 months; placebo supplements during diarrhea episodes

OTHER

Surveillance control group

Active weekly morbidity surveillance for 3 months. New surveillance control group will be randomly assigned to intervention groups every 3 months

Trial Locations (1)

Unknown

Institut de Recherche en Science de la Sante, Bobo-Dioulasso

Sponsors
All Listed Sponsors
collaborator

Université Polytechnique de Bobo-Dioulasso

OTHER

collaborator

Helen Keller International

OTHER

collaborator

Thrasher Research Fund

OTHER

collaborator

Canadian International Development Agency

OTHER_GOV

lead

University of California, Davis

OTHER